Sumitomo Mitsui Trust Holdings, Inc. Crispr Therapeutics Ag Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $156 Billion
- Q2 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 2,414,838 shares of CRSP stock, worth $136 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
2,414,838
Previous 2,539,889
4.92%
Holding current value
$136 Million
Previous $86.4 Million
35.9%
% of portfolio
0.08%
Previous 0.06%
Shares
14 transactions
Others Institutions Holding CRSP
# of Institutions
491Shares Held
64.7MCall Options Held
2.16MPut Options Held
2.1M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$574 Million4.09% of portfolio
-
Capital International Investors Los Angeles, CA6.07MShares$342 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.8MShares$214 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$157 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.54MShares$143 Million1.16% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.4B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....